NUWE vs TIVC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Nuwellis, Inc. exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a devastating 1-year price decline of 96.9%. While the company maintains a low debt-to-equity ratio, its profitability metrics are catastrophic, with a profit margin of -211.86% and an ROE of -382.55%. Revenue growth is stagnant at 4.4%, failing to offset massive operational losses. The technical trend is completely bearish (0/100), suggesting a lack of investor confidence and a high risk of further capital erosion.
TIVC exhibits severe financial distress, anchored by a Piotroski F-Score of 1/9, indicating critical weakness across nearly all fundamental health dimensions. Despite a high current ratio suggesting short-term liquidity, the company is experiencing a catastrophic collapse in revenue (-267.78% Q/Q) and a near-total loss of shareholder value over a 5-year horizon (-100%). While the stock trades at a deep discount to book value (P/B 0.17), the lack of profitability and negative ROE (-82.69%) suggest a value trap rather than a value opportunity.
Compare Another Pair
Related Comparisons
NUWE vs TIVC: Head-to-Head Comparison
This page compares Nuwellis, Inc. (NUWE) and Tivic Health Systems, Inc. (TIVC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.